Table 2.
AGREE II summary of average scores across 4 reviewers for each criterion with average final scores for 9 key items indicated by shaded regions
| Guideline | Domain 1 Scope and Purpose | Domain 2 Stakeholder Involvement | Domain 3 Rigour of Development | Domain 4 Clarity and Presentation | Domain 5 Applicability | Domain 6 Editorial Independence | Average of 4, 7, 8, 10, 12, 13, 15, 22, and 23 | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | ||
| Italian recommendations | 5 | 3 | 7 | 3 | 2 | 7 | 2 | 2 | 2 | 4 | 2 | 2 | 1 | 4 | 6 | 5 | 6 | 5 | 2 | 2 | 1 | 5 | 7 | 33 |
| AAN practice parameter | 7 | 6 | 4 | 3 | 1 | 2 | 7 | 6 | 6 | 4 | 7 | 7 | 7 | 1 | 6 | 6 | 7 | 2 | 4 | 1 | 1 | 6 | 6 | 51 |
| NICE: under 25s | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 6 | 7 | 4 | 7 | 7 | 7 | 7 | 7 | 63 | |
| NICE: adults with CP | 7 | 6 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 63 |
| NICE: under 19s | 6 | 6 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 6 | 6 | 7 | 5 | 7 | 7 | 7 | 6 | 6 | 60 |
| AACPDM dystonia | 6 | 7 | 7 | 6 | 6 | 7 | 7 | 7 | 7 | 6 | 6 | 7 | 6 | 7 | 7 | 6 | 7 | 2 | 5 | 1 | 6 | 6 | 6 | 59 |
| AACPDM osteoporosis | 6 | 7 | 7 | 7 | 6 | 7 | 7 | 7 | 7 | 6 | 7 | 7 | 6 | 7 | 7 | 7 | 7 | 2 | 5 | 1 | 6 | 6 | 6 | 59 |
| Exercise and physical activity | 7 | 5 | 5 | 2 | 1 | 3 | 3 | 5 | 3 | 3 | 5 | 6 | 1 | 1 | 6 | 5 | 6 | 4 | 2 | 2 | 2 | 6 | 6 | 38 |
| Hip surveillance | 7 | 7 | 7 | 5 | 1 | 6 | 7 | 7 | 6 | 7 | 6 | 6 | 4 | 5 | 7 | 6 | 7 | 3 | 4 | 2 | 2 | 6 | 6 | 54 |
| Spasticity | 7 | 5 | 6 | 7 | 1 | 3 | 7 | 6 | 6 | 6 | 6 | 6 | 2 | 1 | 6 | 6 | 6 | 1 | 2 | 1 | 1 | 5 | 6 | 50 |
Abbreviation: AAN, American Association of Neurology.